Study of CBX-12 in Subjects With Advanced or Metastatic Refractory Solid Tumors

Clinical trial NCT04902872 · COMPLETED

Trial details

NCT number: NCT04902872
Sponsor: Cybrexa Therapeutics
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Solid Tumor, Adult Epithelial Ovarian Cancer Small Cell Lung Carcinoma Breast Cancer Colorectal Cancer Pancreas Cancer Appendix Cancer Non-small Cell Lung Cancer Gastric Cancer Esophagus Cancer Urothelial Carcinoma Sarcoma

Start date: 2021-05-03
Primary completion: 2025-06-24
Enrollment: 69

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.